Researchers describe pegcetacoplan, a new class of medication, as the “closest thing to a cure” for the rare, severe kidney disease C3 glomerulopathy.

As nearly one in six couples experience fertility issues, in-vitro fertilization (IVF) is an increasingly common form of ...

AI therapeutics company built on causal biology, today announced the appointment of two scientific advisors: Stephen Hitchcock, Ph.D., a preeminent drug development leader and former Chief Scientific ...

The CRISPR-Cas9 gene-editing tool is as much in the spotlight as it is under scrutiny. Researchers are eager to make genetic modifications to DNA across ...

A research team has developed an optimized regeneration protocol for chili pepper (Capsicum annuum L.), achieving a significant improvement in tissue ...

Results provide strong support for the beneficial effects of low-dose nutrient supplement combinations, the researchers report.

Iron (Fe) is an essential micronutrient for the healthy growth of plants, including many staple crops like rice. Its ...

STRM.BIO, a start-up biotechnology company pioneering non-viral delivery technologies for in vivo cell and gene therapy, ...

A new class of cancer drug has been pushed to an almost unimaginable level of potency in the lab, with researchers reporting ...

VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared the company to proceed with ...